Joint analyses of high-throughput datasets generate the need to assess the association between two long lists of p-values. In such p-value lists, the vast majority of the features are insignificant. Ideally contributions of features that are null in both tests should be minimized. However, by random chance their p-values are uniformly distributed between zero and one, and weak correlations of the p-values may exist due to inherent biases in the high-throughput technology used to generate the multiple datasets. Rank-based agreement test may capture such unwanted effects. Testing contingency tables generated using hard cutoffs may be sensitive to arbitrary threshold choice. We develop a novel method based on feature-level concordance using local false discovery rate. The association score enjoys straight-forward interpretation. The method shows higher statistical power to detect association between p-value lists in simulation. We demonstrate its utility using real data analysis. The R implementation of the method is available at
INTRODUCTION
Omics studies generate test results on thousands of biological features, e.g. genes, SNPs and metabolites. In order to boost statistical power or gain extra insight, there is an interest to jointly analyze datasets from different labs, or from different types of measurements on the same biological features, e.g. expression and splicing of genes. Such joint analyses often involve semi-quantitative assessments on the agreement between experiments. In some situations, comparison can be done by utilizing the raw data and modeling experimentspecific variation and bias [1] . One example is the meta-analysis of microarrays, where datasets from multiple labs are combined to increase the statistical power. Before merging datasets, it is important to examine and compare the characteristics of the datasets, for example by dimension reduction and visualization [2, 3] .
In some other situations, joint analysis of the raw data may be difficult due to computational load or nature of the data. Connectivity map (cmap), which compares a query gene expression signature to a large reference database, uses ranked list comparison based on the Kolmogorov-Smirnov statistic [4] . Other examples include comparing whether the list of differentially expressed genes in two datasets generated from different platforms agree with each other, testing the association between gene expression and alternative splicing, and testing the association of differential splicing between tissues. In such situations, comparisons need to be made on certain feature-level summary values, e.g. test statistics, pvalues, and ranks.
Currently there are a few options for such comparisons. One option is to compare ranked lists [5] [6] [7] . However it is known that rankings are unstable -small perturbations in the data can cause considerable changes in the rankings [8, 9] . In addition, weak correlations of the ranks may exist due to inherent biases in the high-throughput technology used to generate the multiple datasets included in joint analysis. For example, high-throughput RNA sequencing (RNA-Seq) has become a powerful technology for transcriptome analysis [10] . As RNA-Seq represents a sampling of the entire transcriptome, the detection of differential gene expression and alternative splicing by RNA-Seq is inherently biased towards highly expressed genes. Such a bias may result in spurious correlation of the ranks when comparing multiple RNA-Seq datasets. Another option is to use a hard cutoff of false discovery rate (FDR) within each dataset, and tabulate the significant/insignificant features between datasets [11] . Then a test on contingency table can be used to assess the significance of the association. The result may be sensitive to the arbitrary choice of cutoff values. There is a collection of agreement methods in the statistical literature, which are reviewed in [12, 13] . However, such measures are not directly applicable given the lack of interpretability of the scores and the skewness of the data.
Here we report a novel method to assess the association between the two p-value lists. We introduce an association score that has a straight-forward interpretation, and procedures to assess its significance and confidence interval. Utilizing the local false discovery rate (lfdr) concept [14] , the method minimizes the impact of the features that are not significantly associated with the outcome variable in both datasets. It also avoids the arbitrary selection of cutoff values. We demonstrate its superiority over the aforementioned methods in simulations, and its utility using a real dataset.
METHODS

The association score
We utilize local false discovery rate (lfdr) [14] derived from the p-values to make probabilistic assessment. The local false discovery rate is a Bayes posterior probability that a feature is null given its test statistic or p-value [14] . The calculation of local false discovery rate (lfdr) is based on density estimation. Comparatively the false discovery rate (FDR) relies on tail area instead of density [15, 16] . A number of methods were proposed for the calculation of lfdr [14, [17] [18] [19] .
Let the two sets of p-values be and . The local false discovery rate (lfdr) is derived from each set of p-values, In this study we utilize the kernel-based local fdr (kerfdr) method [17] . The kerfdr approach transforms the p-values using a probit transformation, and models the mixture of null and non-null statistics using a two-component mixture model with semi-parametric density estimation [17] . Any other lfdr procedure can be used. The lfdr value for each gene is a probabilistic statement of how likely the gene is non-null in each test.
For an association score, we consider the following ratio: the expected proportion of concordant genes, i.e. genes called null/non-null in both lists, divided by its expected value if the two lists were independent (derived in section 2.2), where N is the total number of genes, m 1 is the sample mean of the lfdr values in experiment one, and m 2 is the sample mean of the lfdr values in experiment two. When the two lists have some level of agreement, i.e. genes called significant in one list is more likely to be called significant in the other list, the value of S is greater than one. If the two lists have no association, the value of S is close to one. Another scenario is the two lists are inversely related, in which case the value of S is less than one.
Permutation test and its normal approximation
Given the empirical distribution of lfdr values derived from the two lists, we can resort to permutation test to find the significance level. The null hypothesis is that the assignment of significance level is independent between the two lists. We can randomly permute one of the lfdr lists M times and compute the test statistic {S (m) } m=1,…,M . The proportion of the sampled permutations with test statistics more extreme than the observed S is taken as the pvalue of the two-sided test,
In the permutation test, the empirical distributions of lfdr (1) and lfdr (2) are fixed, i.e. the values of N, m 1 , and m 2 do not change. Only the part determines the significance. Meanwhile, since the range of value for all the are zero to one, it is easy to prove that both and satisfy the condition required by the permutation central limit theorem [20] . Thus we can use the permutation central limit theorem to illustrate that under the null hypothesis of independence, approximately follows the normal distribution with where N is the length of the p-value vector, m 1 is the sample mean of the lfdr values in experiment one, V 1 is the sample variance of the lfdr values in experiment one, m 2 is the sample mean of the lfdr values in experiment two, and V 2 is the sample variance of the lfdr values in experiment two. Because N is large in the current setting, we can see that under the null hypothesis,
The possible range of the score
It may be useful to assess the score's deviation from one in relation to its maximum possible and minimum possible values, because the statistic S is not confined to a fixed interval. In practical terms, it is unlikely that the similarity score can get close to the maximum/ minimum possible values.
In the permutation setting, the possible range of S can be obtained numerically. It can be easily shown that its maximum possible value is achieved by ordering both lists of lfdr values in an increasing order, and taking the value of the statistic from the re-ordered lists.
Here we consider only the dot product because other parts are constants.
First, suppose we have a 1 ≥ a 2 and b 1 ≥ b 2 . Then because (a 1 − a 2 ) (b 1 − b 2 ) ≥ 0, we have a 1 b 1 + a 2 b 2 ≥ a 1 b 2 + a 2 b 1 . Now considering two longer lists, a 1 ≥ a 2 ≥ · · · ≥ a N ≥ 0 and b 1 ≥ b 2 ≥ · · · ≥ b N ≥ 0. We start with the dot product with any pairing, a 1 b m + a 2 b k + · · · + a q b 1 + · · · + a N b r . Because a 1 b 1 + a q b m ≥ a 1 b m + a q b 1 , we can obtain an equal or higher value by changing the pairing to a 1 b 1 + a 2 b k + · · · + a q b m + · · · + a N b r . Following the same procedure, we then iteratively increase the value of the dot product by considering the pair (a 2 , b 2 ) and so on. In the end, we reach a 1 b 1 + a 2 b 2 + · · · + a N b N , and its value is greater or equal to the dot product we started with. Because the starting point represents any pairing, we have shown that the dot product with matched order achieves the maximum possible value. Similarly, by replacing b i with (1 − b i ) to reverse the order and using the above argument, it can be shown that the minimum possible value of S is achieved by ordering one list in increasing order and the other in decreasing order, and taking the value of the statistic from the reordered lists.
Bootstrap confidence interval
Although the above test provides inference regarding whether the two lists are associated, it doesn't provide the confidence interval for S. Theories of confidence interval on dot product or correlation coefficient cannot be applied in the current setting because the distributions of the lfdr values are highly skewed -the distributions are often "U" shaped with density peaking around zero and one. We resort to bootstrapping to obtain the confidence interval of S. Unlike in the permutation test, the pairing between the two lists is not disrupted. In each bootstrap iteration, we resample N pairs of lfdr values with replacement, and calculate the test statistic from the resampled data. After B iterations, we then take the 2.5 th and 97.5 th percentiles of the test statistic values as the 95% confidence interval of S.
Simulation study
We tested the performance of the proposed method in comparison with three other methods. The first was the ordered list comparison of the p-values [5] . Notice this method is not specifically designed for p-value lists. The second was Fisher's exact test on the contingency table we first dichotomized the p-values into "significant" and "non-significant" based on FDR cutoffs, and then conducted the Fisher's exact test on the 2×2 contingency table. Two FDR cutoffs were tested: 0.1 and 0.2. The third method was testing the significance of the Pearson's correlation coefficient between the two p-value lists.
Each simulated dataset contained two lists of p-values and . In order to generate correlated null p-values between the two lists, we first generated two lists of test statistics and . For genes that were null in both lists, their test statistics were drawn from the bivariate normal distribution with mean and variance-covariance matrix
. Different values of ρ were used (0, 0.2, 0.4 and −0.2) to reflect weak to moderate correlation. For genes that were null in one of the lists, their null test statistics were drawn from the standard normal distribution. Non-null test statistics were drawn from the normal distribution N(−3, 0.5) or N(−4,1). Supporting Figure 1 shows the level of overlap between the null and non-null distributions.
After generating the test statistics, we took the standard normal CDF of the test statistics to generate the p-values, , i = 1,…,N, k =1,2. This way the null gene p-values in each list were uniformly distributed, and the non-null gene p-values were close to zero. For genes that were null in both lists, their correlation coefficient between p-values were very close to the correlation coefficient between the test statistics. Different levels of overlap between non-null genes in the two lists were tested.
RESULTS
Simulation results
Setting the alpha level at 0.05, we compared the statistical power of each method at different simulation settings. Figure 1 shows the results when the total number of genes is 4000, and the non-null test statistics are drawn from N(−3, 0.5). More complete results can be found in the Supplementary Materials. Four methods were compared -our lfdr-based method, ordered list comparison, testing of contingency table, and testing the significance of correlation coefficient between p-value lists. For our method, normal approximation yielded identical results as permutation test. Thus only the normal approximation results are plotted.
In every subplot of Figure 1 , the vertical dotted line represents the number of overlaps when the two sets of non-null genes were drawn independently. A method should yield a power of 0.05 or lower to maintain correct size of the test. The further away from the vertical line, the higher level of association exists between the two lists, where a better method should yield higher power. Every row of Figure 1 represents a different level of correlation between the p-values of null genes in both lists. A better method should be less affected by the correlation of the null genes. Every column of Figure 1 represents a different scenario in terms of the number of non-null genes in each list.
For the ordered list comparison, we used the default method in the R package OrderedList [5] from Bioconductor [21] . The method returns the best result after internally comparing several parameter settings, which causes the size of the test to be incorrect. When the two non-null lists were independently generated (vertical dotted line), OrderedList showed a much higher frequency than 0.05 to call the two lists significantly associated. With incorrect size, the nominal power at other simulation settings become questionable.
Other tests maintained the correct size when the null gene p-values are not correlated ( Fig. 1,  top row) . The test based on p-value correlation shows markedly lower power than the rest. Our method shows higher power than the contingency table-based tests. When weak positive correlation between null gene p-values is present ( Fig. 1, second row) , the test based on pvalue correlation becomes incorrect in size. The performance of our method and the contingency table-based test is only slightly impacted. When the correlation between null gene p-values becomes moderate ( Fig. 1, third row) , We see the curve of all methods shift further to the left. The contingency table based test using FDR cutoff of 0.1 (cyan curve) was least impacted by the correlation, while the contingency table based test using FDR cutoff of 0.2 (orange curve) became incorrect in size when the number of significant genes is larger (Fig. 1, third row, right panel) . We also tested the situation of weak negative correlation between null gene p-values ( Fig. 1, fourth row We show other simulation results in Supporting Figures 2~4. Generally, when the total number of genes is 4000 and the non-null test statistics were generated from N(−4,1), the null gene p-value correlation has even less impact on our method and the contingency tablebased test using FDR cutoff of 0.1 (Supporting Figure 2) . However the contingency tablebased test using FDR cutoff of 0.2 showed worse performance when the null gene p-value correlation is moderate, indicating the sensitivity of the contingency table-based test on the cutoff value (Supporting Figure 2 , third row). We also tested the performance of the methods using simulations where total number of genes is 2000. We kept the same number of non-null genes (200 and 500). In this case the proportion of non-null genes are higher, and the performance of all methods are better. As to the comparison between the methods, the overall trend remains the same (Supporting Figures 3 & 4) .
Prostate cancer data
To demonstrate the utility of the method, we used the prostate cancer datasets in the R package MetaPCA [3] , which were compiled from four separate gene expression studies [22] [23] [24] [25] and subjected to gene filtering based on study-wise mean, variance and missing proportions [3] . All four datasets contain samples in three groups -normal, primary tumor and metastasized tumor. Within each dataset, we first tested differential expression using limma [26] between the normal and primary tumor groups, and between primary and metastasized tumor groups. We then tested the association between the p-value lists of pairs of experiments (Table 1) . All the significant test results were in the positive direction, i.e. the two lists showed higher level of agreement compared to random.
Between normal and primary tumor, the expected number of differentially expressed genes were 649 (Yu), 747 (Lapointe), 780 (Tomlins), and 618 (Varambally) respectively. Using the lfdr-based test, three of the four experiments showed certain levels of agreement (Table  1) , while the Tomlins dataset appeared to generate a significant gene list that was not associated with any of the other three. Testing of contingency table and testing correlation coefficient between p-value lists generated similar result, while the ranked list-based test yielded significant p-values between Tomlins and two other experiments. We then examined the scatter plots of the lfdr values using color representation of smoothed density (Figure 2 ). Between the Tomlins and other datasets, we noticed substantial density at the lower-right and/or upper-left corner, indicating different calls made by different experiments. By checking the original publication, we found the Tomlins dataset was the only one using laser-capture microdissection (LCM) and whole-transcriptome amplification [23] , while the other three datasets were generated from tissue samples. This could explain the difference of gene selection at the global level between the Tomlins and the other three datasets. to similar genes. We tested between the two p-value lists within each experiment. One of the datasets (Varambally) showed no agreement between the two stage transitions, while two other datasets (Lapointe and Tomlins) showed strong agreement. Examining the scatter plots of the lfdr values using color representation of smoothed density (Figure 3 ), we noticed that the lack of agreement of Yu and Varambally datasets were caused by substantial density at the lower-right corner, i.e. large number of genes called insignificant in normal v.s. tumor test, but significant in tumor v.s. metastasis test, which could well be explained by the progression of tumor leading more genes to be differentially expressed. Thus the lack of agreement cannot be taken at its face value here.
In all three sets of comparisons, we notice that in all cases where a majority of the tests claimed significant association, the lfdr-based test always shows the smallest p-value. On the other hand, in the cases where all tests yielded insignificant results, the lfdr-based test doesn't show any tendency of generating smaller p-values than the others (Table 1 ).
Comparing gene expression in multiple types of cancer
We analyzed gene expression data derived from tissue samples of multiple cancer types using the Affymetrix U133A or U133 Plus 2.0 arrays. Most of the data were downloaded from the Gene Expression Omnibus (GEO) [27] . The data we studied include five breast cancer datasets GSE5364 [28] , GSE5847 [29] , GSE10780 [30] , GSE15852 [31] , GSE29431 (no reference available); four lung cancer datasets GSE7670 [32] , GSE10072 [33] , GSE18842 [34] , GSE19804 [35] ; five colorectal cancer datasets GSE18105 [36] , GSE21510 [37] , GSE22598 [38] , GSE24514 [39] , GSE23878 (no reference available); three renal cancer datasets GSE14762 [40] , GSE6344 [41] , GSE781 [42] ; and four oral cancer datasets GSE30784 [43] , GSE31056 [44] , GSE9844 [45] , and a dataset published by Ziober et al that is not in GEO [46] . For each dataset, we first obtained the gene level p-values by testing between normal and cancer phenotype using LIMMA [26] . We then selected the overlapping probesets of the arrays. As all the datasets involved were generated using Affymetrix U133A or U133 Plus 2.0 arrays, 22277 probesets were present in all the datasets. Thirdly, we matched the probesets to ENTREZ gene IDs. A total of 12713 ENTREZ genes were found in all datasets. In the case where an ENTREZ gene was represented by more than one probesets, the geometric mean of the corresponding p-values was taken as the pvalue of the gene.
First, we examined the global agreement between all pairs of datasets using all the 12713 genes. The p-values between most dataset pairs are small, indicating a certain level of association across all the cancer types under study. The large number of genes made the statistical power very high to detect even weak associations. For better visual comparison, we use a heatmap of the test statistic (Fig. 4) . The lung cancer and oral cancer datasets clearly showed higher within-type association, while the breast cancer datasets appeared to be heterogeneous.
It is expected that different biological pathways may behave differently in various cancer types. With our new tool to assess association of the p-values of groups of genes between datasets, we examined which biological functions tend to be differentially regulated between cancer types. We note that here we assess the behavior of biological processes only based on the genes' first-order relations with the clinical phenotype, i.e. control v.s. a certain type of cancer. In order to map genes to biological functions/pathways, we resorted to the functional annotations by Gene Ontology (GO) [47] . We downloaded the GO slim terms that are a set of relatively broad ontologies pertaining to various aspects of the biological system [47] . We assessed the association between datasets using each GO slim term that is assigned more than 200 human ENTREZ genes. A total of 74 GO slim terms were included in this study. The number of genes assigned to these terms range from 202 to 4064.
For each dataset, we first found the p-values of all the 12713 genes. We then transformed the p-values into lfdr values using kerfdr. For each GO slim term, we selected the genes assigned to the term. Using the lfdr values of these genes, we conducted the test of association between all pairs of datasets. With a p-value cutoff of 0.001 to offset the large number of tests conducted, we found which dataset pairs were associated based on each GO slim term. Our purpose was to find which GO slim terms behave more consistently within cancer types, compared to between cancer types. For this purpose, the 'ideal' GO slim term should generate significant test result on pairs of datasets of the same cancer type, while generating insignificant results on pairs of datasets of different cancer types. Thus we considered dataset pairs from the same cancer type "true positives", and pairs from different cancer types "true negatives". We then used the balanced accuracy, i.e. the average value of sensitivity and specificity to summarize the result from each GO slim term, Because the breast cancer datasets were highly inconsistent, we put more emphasis on other cancer types when summarizing the results. We ordered the GO slim terms based on their balanced accuracy on the datasets excluding the breast cancer datasets. The GO slim terms showing highest and lowest balanced accuracy are shown in Table 2 . The complete results of all 74 GO slim terms is in Supporting Table 1 . We noticed that the rankings agree very well with and without the breast cancer datasets.
The top 10 GO slim terms showed two clear themes ( Table 2 ). The first theme is cellular and intercellular structures, including GO:0048646 (anatomical structure formation involved in morphogenesis), GO:0007155 (cell adhesion), GO:0008092 (cytoskeletal protein binding), and GO:0007010 (cytoskeleton organization). This is easy to interpret as different cancer types are derived from tissues of distinct structural characteristics. The second theme is small molecule metabolism and energy generation, including GO:0006520 (cellular amino acid metabolic process), GO:0006629 (lipid metabolic process), GO:0008289 (lipid binding), GO:0005739 (mitochondrion), GO:0008233 (peptidase activity), and GO:0016491 (oxidoreductase activity). It is known that the metabolism of small molecules including key amino acids is associated with the proliferation of cancer cells [48] , and cancer cells may reprogram metabolism to attain nutrient self-sufficiency [49] . The results on GO slim terms indicate different types of cancer may behave differently in the small molecule metabolism reprogramming. We further examined the results between pairs of datasets using heatmaps. By plotting the results from the GO slim term GO:0006520 (cellular amino acid metabolic process), we found that most within-type dataset pairs (except breast cancer) were called significant, while most between-type dataset pairs were called insignificant (Fig. 5 ). The same pattern was observed using the two terms with the next highest balanced accuracy scores GO:0005739 (mitochondrion) (Supporting Figure 5 ) and GO:0008289 (lipid binding) (Supporting Figure 6 ).
The bottom 10 GO slim terms were less cohesive in terms of their functional relations. An interesting observation was three terms related to cell cycle, GO:0051301 (cell division), GO:0007067 (mitosis) and GO:0000228 (nuclear chromosome), were included. We examined the results between pairs of datasets using heatmaps. By plotting the results from the GO slim term that generated the lowest balanced accuracy, GO:0000228 (nuclear chromosome), we found that datasets from breast cancer and renal cancer do not show within-cancer type associations, while datasets from oral, lung, and colorectal cancers showed heavy cross-caner type associations (Fig. 6 ). Another GO slim term in the bottom 3, GO:0007067 (mitosis), showed a similar pattern (Supporting Figure 8 ). These results indicate there might be some relations between the cell cycle behaviors of oral, lung and colorectal cancer cells, while the cell cycle behaviors of renal and breast cancers are divergent, even within the same cancer type. Another GO slim term in the bottom three, GO: 0005886 (plasma membrane), generated results showing broad dependencies both within and between cancer types (Supporting Figure 7) , indicating a broad association across cancer types of the behavior of the genes in this GO term.
DISCUSSION
Overall, our lfdr-based test achieves high statistical power to detect associations between pvalue lists, and it is resistant to weak to moderate correlations between null gene p-values. Our test statistics uses the expected proportion of concordant genes. The permutation test assumes that the distribution of the p-values in each list is fixed. Given that the user doesn't re-examine the raw data, this is a reasonable assumption that is also used by the ranked list comparison and the contingency table approach. The inference using permutation test and normal approximation yielded identical results, suggesting that the normal approximation, which has very little computing cost, is appropriate when the number of genes are in the thousands.
Because our test is centered around the dot product between the two lfdr vectors, the permutation test is equivalent to the test of significance of Pearson's correlation coefficient between the lfdr vectors. Although we do prefer the more interpretable test statistic presented in this manuscript, our results does provide a justification of directly testing the significance of Pearson's correlation coefficient between the lfdr vectors, even though the distribution of lfdr values is far from normal. The inference of confidence interval by bootstrapping doesn't converge to the theoretical confidence interval derived from dot product or correlation coefficient that rely on normality assumption, which is caused by the extreme skewness of the lfdr value distribution.
Our method is based on the local fdr concept, and the result depends on the correct estimation of the local fdr values from the p-values, which requires the correct tuning of the lfdr procedure. Using the simulation settings presented in Figure 1 , we tested three other local fdr procedures available in R: locfdr [50] , twilight [51] , and fdrtool [19] , all at default settings. The procedures locfdr and fdrtool generated almost identical results as kerfdr (Supporting Figure 9 ). Twilight results are almost identical to the others when there is no correlation between null gene p-values. In the presence of correlation, the twilight results are more impacted by the correlation (Supporting Figure 9 ).
Overall, we presented a method to assess the association between p-value lists. The method can be used to find agreement between experiments by directly comparing the p-value lists. Similar to rank-based agreement methods, our method can help assess the level of agreement between datasets before meta-analysis, or find associations between different types of measurements on the same set of biological features. Comparing the size and power of the methods. Rows: different levels of correlation between null genes in both tests. Columns: different numbers of non-null genes. N1: number of nonnull genes in list 1; N2: number of non-null genes in list 2. Vertical line: expected number of overlaps when the non-null genes are independently drawn; horizontal line: the alpha level 0.05 as a reference for examining the size of the tests. The total number of genes is 4000. For genes that are null in both tests, their test statistic was generated from a bivariate normal distribution with mean and variance-covariance matrix . Otherwise the null test statistic was simulated from the standard normal distribution; the non-null statistic was simulated from a normal distribution with mean of −3 and standard deviation of 0.5. The pvalues were generated from the test statistics using standard normal CDF. Heatmap of the test statistic between pairs of datasets using all genes. Testing the association between pairs of experiments using the gene list of GO term GO: 0006520 -cellular amino acid metabolic process. Significance levels of between-dataset associations are presented as a heatmap. P-value cutoff is 0.001. Testing the association between pairs of experiments using the gene list of GO term GO: 0000228 -nuclear chromosome. Significance levels of between-dataset associations are presented as a heatmap. P-value cutoff is 0.001. 
